RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis

Allan L. Klein, Massimo Imazio, Antonio Brucato, Paul Cremer, Martin M. LeWinter, Antonio Abbate, David Lin, Alberto Martini, Anna Beutler, Steven Y. Chang, Fang Fang, Anais Gervais, Randy Perrin, John F. Paolini